Multisystem Inflammatory Syndrome in Adult after First Dose of mRNA Vaccine

A 32-year-old man in Japan experienced respiratory failure after receiving the first dose of coronavirus disease (COVID-19) vaccine. He was treated with noninvasive ventilation and corticosteroids. Serologic test results suggested previous COVID-19; therefore, he received a diagnosis of multisystem...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyazato, Yusuke, Yamamoto, Kei, Yamada, Gen, Kubota, Shuji, Ishikane, Masahiro, Sugiyama, Masaya, Ueno, Mikako, Matsunaga, Akihiro, Miyoshi-Akiyama, Tohru, Ishizaka, Yukihito, Ohmagari, Norio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962876/
https://www.ncbi.nlm.nih.gov/pubmed/35148495
http://dx.doi.org/10.3201/eid2804.212585
Descripción
Sumario:A 32-year-old man in Japan experienced respiratory failure after receiving the first dose of coronavirus disease (COVID-19) vaccine. He was treated with noninvasive ventilation and corticosteroids. Serologic test results suggested previous COVID-19; therefore, he received a diagnosis of multisystem inflammatory syndrome. COVID-19 vaccination could be a trigger for this condition.

Ejemplares similares